echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Bollinger Ingeheim's new drug Arti-Cell® Forte to be listed in Europe

    Bollinger Ingeheim's new drug Arti-Cell® Forte to be listed in Europe

    • Last Update: 2020-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    lameness is a common problem for horses and has an impact on their performance and animal welfareCurrent treatments cannot address the needs of all cases, and the industry is looking forward to innovative treatment options, so it is particularly focused on how to overcome the underlying causes beyond the symptomsrecently, Bollinger Ingeheim was listed in Europenew drug(http://Arti-Cell® Forte, to reduce mild recurrent lameness in horses caused by non-pusy joint infectionsArti-Cell® Forte treats lameness with specifically activated cartilage-induced stem cells, the first breakthrough treatmentdrug(http://approvedArti-Cell® Forte is a ready-to-use ultra-low temperature refrigerant formBollinger Ingerham partnered with Global Stem Cell Technology (GST) last year to provide new treatments and solutions to improve animalhealth(http://So Arti-Cell® Forte is a convenient, long-lasting (2) solution developed specifically for horse's limpingArti-Cell ® Forte has been approved to treat horse lameness after a scientific review by the EuropeanMedicines(http://Authority (2) and the European Commission's EU listing approvalthe(http://of theproduct will be available in Europe from May and June 2019
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.